393547-07-4

Upstream product

• 393548-65-7 (S)-1-Benzyl-3-((S)-2-tert-butoxycarbonylamino-3-methyl-butyryl)-2-oxo-imidazolidine-4-carboxylic acid 
• 393548-68-0 (3-{[(S)-1-Benzyl-3-((S)-2-tert-butoxycarbonylamino-3-methyl-butyryl)-2-oxo-imidazolidine-4-carbonyl]-amino}-2-hydroxy-hexanoylamino)-acetic acid allyl ester 
• 89371-88-0 benzyl (4S)-1-benzyl-3-benzyloxycarbonyl-2-oxo-imidazolidine-4-carboxylate 
• 89371-46-0 benzyl (4S)-1-benzyl-2-oxoimidazolidine-4-carboxylate 

Downstream Products

• 393547-09-6 (3-{[(S)-3-((S)-2-Amino-3-methyl-butyryl)-1-benzyl-2-oxo-imidazolidine-4-carbonyl]-amino}-2-oxo-hexanoylamino)-acetic acid allyl ester 
• 393547-13-2 4-(2-acetylamino-4-tert-butoxycarbonyl-butyrylamino)-4-[1-(1-{5-[1-(allyloxycarbonylmethyl-aminooxalyl)-butylcarbamoyl]-3-benzyl-2-oxo-imidazolidine-1-carbonyl}-2-methyl-propylcarbamoyl)-2-methyl-propylcarbamoyl]-butyric acid tert-butyl ester 

Relevant academic research and scientific papers

Novel 2-oxoimidazolidine-4-carboxylic acid derivatives as Hepatitis C virus NS3-4A serine protease inhibitors: Synthesis, activity, and X-ray crystal structure of an enzyme inhibitor complex

Synthesis and HCV NS3 serine protease inhibitory activity of some novel 2-oxoimidazolidine-4-carboxylic acid derivatives are reported. X-ray structure of an inhibitor, 15c bound to the protease is presented. Synthesis and HCV NS3 serine protease inhibitor